Imunon
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Imunon and other ETFs, options, and stocks.About IMNN
Imunon, Inc. is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies.
CEOStacy R. Lindborg
CEOStacy R. Lindborg
Employees20
Employees20
HeadquartersLawrenceville, New Jersey
HeadquartersLawrenceville, New Jersey
Founded1982
Founded1982
Employees20
Employees20
IMNN Key Statistics
Market cap12.16M
Market cap12.16M
Price-Earnings ratio-0.39
Price-Earnings ratio-0.39
Dividend yield—
Dividend yield—
Average volume36.25K
Average volume36.25K
High today$3.20
High today$3.20
Low today$3.00
Low today$3.00
Open price$3.00
Open price$3.00
Volume42.47K
Volume42.47K
52 Week high$47.40
52 Week high$47.40
52 Week low$2.52
52 Week low$2.52
Stock Snapshot
With a market cap of 12.16M, Imunon(IMNN) trades at $3.10. The stock has a price-to-earnings ratio of -0.39.
As of 2026-04-14, Imunon(IMNN) stock has fluctuated between $3.00 and $3.20. The current price stands at $3.10, placing the stock +3.3% above today's low and -3.1% off the high.
The Imunon(IMNN)'s current trading volume is 42.47K, compared to an average daily volume of 36.25K.
During the past year, Imunon(IMNN) stock moved between $2.52 at its lowest and $47.40 at its peak.
During the past year, Imunon(IMNN) stock moved between $2.52 at its lowest and $47.40 at its peak.
People also own
Based on the portfolios of people who own IMNN. This list is generated using Robinhood data, and it’s not a recommendation.